Profound Medical Corp.
PROF
$4.78
$0.061.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.79% | -6.71% | 4.45% | -2.15% | 1.21% |
| Total Depreciation and Amortization | 0.75% | 60.24% | 47.96% | 12.00% | -7.47% |
| Total Amortization of Deferred Charges | -- | -77.33% | -84.83% | -92.33% | -- |
| Total Other Non-Cash Items | -57.40% | -49.21% | -48.32% | -44.10% | -35.71% |
| Change in Net Operating Assets | 335.98% | 308.78% | 85.98% | 118.05% | 106.27% |
| Cash from Operations | -3.73% | -14.81% | 0.86% | 7.91% | 12.37% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -180.70% | -171.52% | -147.69% | -139.89% | -156.18% |
| Issuance of Common Stock | 2,229.50% | 761.22% | 710.78% | 765.04% | 914.45% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1,147.65% | -1,147.65% | -1,147.65% | -- |
| Cash from Financing | 3,014.81% | 110.24% | 109.07% | 116.16% | -75.02% |
| Foreign Exchange rate Adjustments | -563.39% | -158.52% | -1,328.95% | 103.24% | 129.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 241.35% | 48.33% | 62.78% | 89.47% | 1.60% |